Results 81 to 90 of about 13,189,470 (203)

Intrapulmonary disposition of amphotericin B after aerosolized delivery of amphotericin B lipid complex (Abelcet; ABLC) in lung transplant recipients

open access: yes, 2010
Background. Inhaled amphotericin preparations have been used for prophylaxis against invasive aspergillosis in lung transplant recipients. However, no published data exist regarding the pharmacokinetic profile of amphotericin B lipid complex in lung ...
Johnson, Bruce   +27 more
core   +1 more source

EPR studies of Cladosporium cladosporioides complexes with amphotericin B [PDF]

open access: yes, 2013
Free radicals in Cladosporium cladosporioides cultured with amphotericin B were spectroscopically studied. The effect of drug concentrations on free radicals in the fungal melanin biopolymer was examined.
Zdybel, M.   +3 more
core  

Filamentation protects Candida albicans from amphotericin B-induced programmed cell death via a mechanism involving the yeast metacaspase, MCA1

open access: yes, 2016
The budding yeast Candida albicans is one of the most significant fungal pathogens worldwide. It proliferates in two distinct cell types: blastopores and filaments.
Morgan L. McCarthy   +4 more
core   +1 more source

Amphotericin B molecular graph and its graph of cycles.

open access: yes, 2019
According to the definition of graph of cycles, we compute the graph of cycles of the molecule Amphotericin B.
Dominique Barth (788895)   +5 more
core   +1 more source

Formulation of amphotericin B as nanosuspension for oral administration.

open access: yes, 2003
Amphotherin B was formulated in a nanosuspension as a new oral drug delivery system for the treatment of experimental visceral leishmaniasis. Amphotericin B (AmB) nanosuspensions were produced by high pressure homogenisation obtaining particles with a ...
Kiderlen, AF   +4 more
core   +1 more source

Preventing or attenuating amphotericin B nephrotoxicity with dopamine receptor agonists: a literature review

open access: yesTrends in Pharmaceutical Sciences, 2016
Nephrotoxicity is generally considered as the most clinically significant and dose-limiting adverse reaction of amphotericin B. Currently, only the clinical effectiveness of salt loading and administering lipid formulations of amphotericin B have been ...
Iman Karimzadeh   +2 more
doaj  

Amphotericin B resistance in Leishmania amazonensis: In vitro and in vivo characterization of a Brazilian clinical isolate.

open access: yesPLoS Neglected Tropical Diseases
In Brazil, Leishmania amazonensis is the etiological agent of cutaneous and diffuse cutaneous leishmaniasis. The state of Maranhão in the Northeast of Brazil is prevalent for these clinical forms of the disease and also has high rates of HIV infection ...
Bianca A Ferreira   +7 more
doaj   +1 more source

Cytokines released from kidney cells exposed to Amphotericin B.

open access: yes, 2008
Color poster with text and tables describing research conducted by Ben Bonis, advised by Lloyd Turtinen.A human proximal tubule kidney cell culture (HK-2) was established as a cell model for the study of Amphotericin B-induced nephrotoxicity. Exposure to
Bonis, Ben
core  

Patterns of Amphotericin B Use and Factors Related to Mortality in a Low-Middle Income Country: An Observational and Longitudinal Study

open access: yesAntibiotics
Background/Objectives: Amphotericin B is indicated in deep systemic fungal infections. The aim was to determine the sociodemographic, clinical and pharmacological variables of a group of Colombian patients treated with amphotericin B and factors ...
Luis Fernando Valladales-Restrepo   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy